Prostate Cancer Pods Social Media Toolkit

WE ARE THRILLED TO HAVE YOU AS PART OF OUR FACULTY! Thank you for joining us for our upcoming educational activity. We’d like to ask for your help to ensure your involvement as a faculty member is shared with your colleagues and network. Here are a few easy ways you can let your network know about your involvement as a faculty member. Thank you for helping us spread the word and make this activity a success!

Tag Us on Social Media!

LinkedIn: CME Outfitters, LLC

Facebook: CME Outfitters

Twitter: @CMEOutfitters

Instagram: @CMEOutfitters

YouTube: CME Outfitters

TikTok: @CMEOutfitters

Consider posts on Twitter, LinkedIn, Facebook, Instagram.When you post, please use our hashtag: #cmeoutfitters

Disease States and Staging of Castration-Sensitive Prostate Cancer

Participate Now

The first episode of this CME Outfitters podcast series on castration-sensitive prostate cancer (CSPC) will outline the current state of staging in CSPC and clarify the findings of reports detailing the pathology of prostate cancer specimens.

Treatment Options and Clinical Dilemmas in Biochemical Recurrence

Participate Now

This CME Outfitters podcast will focus on how clinicians can individualize treatment decisions, based on the use of risk assessment algorithms and advanced imaging techniques with greater ability to detect the sites and extent of disease at BCR. These tools have already demonstrated the ability to change treatment decisions and will substantially impact the management of patients with BCR after radical prostatectomy.

Sorting Out the Androgen Deprivation Therapy Options for Locally Advanced CSPC

Participate Now

This CMEOCast episode will aim to improve knowledge and competence in integrating the latest data on the management of patients with early-stage prostate cancer by evaluating strategies for its management and differentiating the potential for adverse effects between androgen deprivation therapies.

Management of Patients with Metastatic Castration-Sensitive Prostrate Cancer

Participate Now

In this CME Outfitters podcast, expert faculty focus on patient selection criteria for second-generation antiandrogen therapy and the role of molecular testing risk stratification of patients with metastatic CSPC.

Tip: A picture is worth a thousand words – share the featured graphic below in your posts.

Graphics (Click to Download)

Click to Post Templates:

Click to post on Twitter: I recently hosted a @cmeoutfitters podcast series on #ProstateCancer. Tune in now and earn free CME/CE credit: https://cmeo.me/ProstateCancerPods #cmeoutfitters #OncologyTwitter #OncTwitter #prostatecancerawareness

Click to post on Facebook and LinkedIn: I recently hosted a @cmeoutfitters podcast series on #ProstateCancer. Tune in now and earn free CME/CE credit: https://cmeo.me/ProstateCancerPods #cmeoutfitters

Click to email:

Dear Colleague,

I’d like to invite you to tune in to my CME Outfitters podcast series on Prostate Cancer. You can learn more about these activities and earn free CME/CE credit here: https://cmeo.me/ProstateCancerPods.